Germany Contraceptive Devices Market Report 2022 to 2030

Germany Contraceptive Devices Market Analysis

$ 3999

Germany's Contraceptive Devices Market is expected to witness growth from $472 Mn in 2022 to $764 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-30. The German populace is becoming more educated and aware of issues related to sexual health and contraception. The government and NGOs have taken steps to educate young people about the value of contraception, which has resulted in a rise in the use of contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Riemser Arzneimittel, Femcare Medizintechnik, Bayer, Mylan Laboratories, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

ID: IN10DEMD005 CATEGORY: Medical Devices GEOGRAPHY: Germany AUTHOR: Jigyasu Bhandari

Buy Now

Germany Contraceptive Devices Healthcare Market Executive Analysis

Germany's Contraceptive Devices Market size is at around $472 Mn in 2022 and is projected to reach $764 Mn in 2030, exhibiting a CAGR of 6.20% during the forecast period. In 2023, recent health spending in Germany will comprise 13% of GDP. In 2021, the government paid for all of Germany's healthcare expenses with transfers and other financial aid reaching $72,05 Bn. A $17.30 billion, or 31.5%, increase from 2020, Therefore, 15.7% of the $4,581 Bn in current health expenditures, an increase of 3% from the previous year, were made up of government transfers and subsidies.

In Germany, many people use contraceptive methods, and those who want to avoid getting pregnant have a variety of choices. Condoms, oral contraceptive pills, intrauterine devices, contraceptive patches, and vaginal rings are some of the most widely used contraceptives in Germany. The use of condoms is frequently recommended for people who want to avoid getting pregnant while simultaneously preventing STIs. They can be obtained through pharmacies, supermarkets, and other retailers and are generally accessible in Germany. In Germany, oral contraceptives are also frequently utilized. They contain hormones that thicken cervical mucus and stop ovulation, making it more difficult for sperm to reach the egg. A doctor's prescription is required for these medications. When placed on the skin, contraceptive patches release hormones that stop ovulation. For three weeks, a new patch is applied every week, then there is a week without applying any patches. They are modified once per week. A doctor's prescription is required to purchase contraceptive patches.

Germany Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

The German populace is becoming more educated and aware of issues related to sexual health and contraception. The government and NGOs have taken steps to educate young people about the value of contraception, which has resulted in a rise in the use of contraceptive methods. Long-Acting Reversible Contraceptives (LARC) methods of contraception including IUDs and implants, which provide long-term protection against unplanned births, are becoming more and more popular. This is a result of their high rate of efficacy, convenience, and usability. The German market is seeing an increase in demand for these gadgets as a result. In Germany, there is a rising proportion of women in the labour force, which has increased the use of contraceptive methods. In order to focus on their careers and personal objectives, women are looking for contraceptive methods that provide them with control over their reproductive health.

Market Restraints

The German market for contraceptive devices is quite competitive, with both native and foreign producers present. The manufacturers are engaged in a pricing war as a result of the intense rivalry. Manufacturers now have lower profit margins, which makes it difficult to maintain growth over the long term. Rural communities may have a limited supply of contraceptive options, making it difficult for residents to access and use these options. The market for manufacturers may be constrained as a result, especially if they target rural areas.

Competitive Landscape

Key Players

Riemser Arzneimittel (DE)
Femcare Medizintechnik (DE)
Bayer (DE)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Recent Notable Deals

2021: A strategic agreement between Natural Cycles and Bayer was announced in 2021. Natural Cycles is a Swedish digital health startup that provides a hormone-free contraception app. By working together, the two companies hoped to increase women's access to the Natural Cycles app and offer them a more complete selection of digital contraceptives.

Healthcare Policies and Regulatory Landscape

In Germany, the principal regulation controlling contraceptive devices is the Medical Devices Act. It outlines specifications for the development, production, and distribution of contraceptive devices, as well as procedures for testing and certification, post-market monitoring, and reporting. Contraceptive products sold in Germany are required to have the CE symbol. This shows that the equipment complies with the Medical Devices Directive's fundamental health and safety standards. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) is the regulatory organisation in charge of overseeing the security and effectiveness of contraceptive methods. Its duties include examining and approving requests for marketing authorisation for contraceptive devices, as well as carrying out risk management and post-market surveillance procedures.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.